Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice

SIMPLE SUMMARY: A diagnosis of diffuse large B-cell lymphoma in our therapeutic era should be implemented by the definition of the cell of origin, additional immunohistochemistry (i.e., BCL2 and MYC), and by fluorescent in-situ hybridization. The next step, suggested by the seminary works we will di...

Descripción completa

Detalles Bibliográficos
Autores principales: Visco, Carlo, Tanasi, Ilaria, Quaglia, Francesca Maria, Ferrarini, Isacco, Fraenza, Costanza, Krampera, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600909/
https://www.ncbi.nlm.nih.gov/pubmed/33050534
http://dx.doi.org/10.3390/cancers12102913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600909/
https://www.ncbi.nlm.nih.gov/pubmed/33050534
http://dx.doi.org/10.3390/cancers12102913

Ejemplares similares